NasdaqCM:SNDLPharmaceuticals
Why SNDL (SNDL) Is Up 12.3% After Renewing Buybacks Amid US Cannabis Rescheduling Hopes
Recently, SNDL Inc. renewed its share repurchase program of up to C$100 million and saw sentiment strengthen after reports that the Trump administration may push to reclassify marijuana to Schedule III in the US, a move that could ease tax and financing constraints across the cannabis industry.
Although SNDL remains primarily focused on Canada, shifting expectations around US federal cannabis policy are increasingly influencing how investors view its long-term optionality and capital...